Imke Bruns
Promovendus
- Naam
- I.B. Bruns
- Telefoon
- 071 5276039
- i.b.bruns@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0001-9681-6693
Voor meer informatie zie Engelse profielpagina.
Promovendus
- LACDR
- Divisie Cell systems and Drug Safety
- Di Tillio F., Wijaya L., Kunnen S., Eugenio C.J., Buzzanca G., Bruns I., Martens M., Kramer N., Kers J., Callegaro G., Water B. van de & Beltman J.B. (2026), Quantitative adverse outcome pathway modeling of cisplatin-induced nephrotoxicity: developing in vitro and in vivo models for predictive extrapolation, Toxicological Sciences 209(2): kfaf177.
- du Long R., Florquin M.S.N.C., Bemelman F.J., Claessen N., Varin A., Lamarthée B., Water B. van de, Bruns I.B., Callegaro G., Baelde H.J., Helm D. van der, Vries A.P.J. de, Peters-Sengers H., Florquin S. & Kers J. (2026), Clinicopathological and molecular characteristics of plasma cell-rich rejection in renal transplant biopsies, Transplantation : .
- Bruns I.B., Schultz D.R., Demuynck E., Dewulf F., Theologidis I., Kunnen S.J., Wijaya L.S., Frydas I., Papaioannou N., Renieri E., Papageorgiou T., Sarigiannis D., Machera K., Mertens B., Asselman J., Weiss C., Water B. van de & Callegaro G. (2026), Analytical choices drive toxicogenomic potency estimates: a systematic evaluation of transcriptomic points of departure, Toxicological Sciences 209(9): kfag115.
- Bruns I.B., Li Y., Stevens J.L., Water B. van de & Callegaro G. (2025), Cell type heterogeneity in gene co-expression networks: implications for toxicological research, Briefings in Bioinformatics 26(4): bbaf421.
- Bruns I.B. & Beltman J.B. (2022), Quantifying the contribution of transcription factor activity, mutations and microRNAs to CD274 expression in cancer patients, Scientific Reports 12(1): 4374.